Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

Added 131 days ago (11.01.2022)
Authors: Mingrone, G., van Baar, A. C., Deviere, J., Hopkins, D., Moura, E., Cercato, C., Rajagopalan, H., Lopez-Talavera, J. C., White, K., Bhambhani, V., Costamagna, G., Haidry, R., Grecco, E., Galvao Neto, M., Aithal, G., Repici, A., Hayee, B., Haji, A., Morris, A. J., Bisschops, R., Chouhan, M. D., Sakai, N. S., Bhatt, D. L., Sanyal, A. J., Bergman, J. J. G. H. M., Investigators of the REVITA-2 Study, Grecco, Santomauro, Bergman, Nieuwdorp, Morris, Drummond, Carty, Deviere, Crenier, Moura, Cercato, Repici, Lania, Betella, Hopkins, Hayee, Haji, Ragunath, Idris, Chee, Mingrone, Costamagna, Guidone, Haidry, Batterham, Bisschops, Mertens
Journal: Gut
Read article